TLR4 and ischemic stroke: A study observing improvement of neurological function in diabetic rats during ischemic stroke found that SGB can inhibit the Toll-like receptor 4/nuclear factor kappa B signaling pathway and reduce the inflammatory response in the plasma of rats [22].